163 filings
Page 2 of 9
6-K
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
AMYT
Amryt Pharma Plc
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
AMYT
Amryt Pharma Plc
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am
6-K
AMYT
Amryt Pharma Plc
9 Jun 22
Current report (foreign)
7:17am
6-K
AMYT
Amryt Pharma Plc
1 Jun 22
Current report (foreign)
6:05am
EFFECT
AMYT
Amryt Pharma Plc
23 May 22
Notice of effectiveness
12:15am
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
EFFECT
AMYT
Amryt Pharma Plc
19 May 22
Notice of effectiveness
12:15am
EFFECT
AMYT
Amryt Pharma Plc
19 May 22
Notice of effectiveness
12:15am
CORRESP
AMYT
Amryt Pharma Plc
18 May 22
Correspondence with SEC
12:00am
UPLOAD
AMYT
Amryt Pharma Plc
18 May 22
Letter from SEC
12:00am
F-3
AMYT
Amryt Pharma Plc
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
AMYT
Amryt Pharma Plc
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
AMYT
Amryt Pharma Plc
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
AMYT
Amryt Pharma Plc
11 May 22
Current report (foreign)
4:30pm
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
7:45am
6-K
AMYT
Amryt Pharma Plc
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am